Economic Evaluations of Pharmacological Treatment for Opioid Use Disorder: a Systematic Literature Review

There is new evidence on buprenorphine and strengthened evidence on methadone indicating both are economically advantageous treatments for opioid use disorder.

Saved in:
Bibliographic Details
Published inValue in health Vol. 24; no. 7; pp. 1068 - 1083
Main Authors Onuoha, Erica N., Leff, Jared A., Schackman, Bruce R., McCollister, Kathryn E., Polsky, Daniel, Murphy, Sean M.
Format Journal Article
LanguageEnglish
Published 08.05.2021
Online AccessGet full text

Cover

More Information
Summary:There is new evidence on buprenorphine and strengthened evidence on methadone indicating both are economically advantageous treatments for opioid use disorder.
Bibliography:ENO performed the initial database searches to identify pertinent articles. Studies were included on the basis of a consensus among authors [ENO, JAL, SMM] following rigorous discussion. Three coauthors reviewed the Drummond checklist and agreed on results [ENO, JAL, SMM]. [ENO, JAL, SMM] drafted the manuscript and [BRS, KEM, DP] provided critical feedback on the manuscript. All authors signed-off on the final version. The authors wish to thank Janet Weiner, PhD, for his comments on an earlier draft of the manuscript.
Author Contributions
ISSN:1098-3015
1524-4733
DOI:10.1016/j.jval.2020.12.023